Ingevity (NGVT) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to $1.18.
- Ingevity's EPS (Weighted Average and Diluted) rose 14013.61% to $1.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.82, marking a year-over-year increase of 8823.53%. This contributed to the annual value of -$11.85 for FY2024, which is 780000.0% down from last year.
- Latest data reveals that Ingevity reported EPS (Weighted Average and Diluted) of $1.18 as of Q3 2025, which was up 14013.61% from -$4.02 recorded in Q2 2025.
- Over the past 5 years, Ingevity's EPS (Weighted Average and Diluted) peaked at $1.98 during Q3 2022, and registered a low of -$7.81 during Q2 2024.
- Over the past 5 years, Ingevity's median EPS (Weighted Average and Diluted) value was $0.69 (recorded in 2023), while the average stood at -$0.31.
- In the last 5 years, Ingevity's EPS (Weighted Average and Diluted) surged by 190000.0% in 2022 and then plummeted by 90515.46% in 2024.
- Over the past 5 years, Ingevity's EPS (Weighted Average and Diluted) (Quarter) stood at $0.74 in 2021, then tumbled by 40.54% to $0.44 in 2022, then crashed by 822.73% to -$3.18 in 2023, then surged by 114.47% to $0.46 in 2024, then skyrocketed by 156.52% to $1.18 in 2025.
- Its last three reported values are $1.18 in Q3 2025, -$4.02 for Q2 2025, and $0.56 during Q1 2025.